GlassScriptPhysician profile
Lauren M Sullivan
NPI 1285147850
$3,073.62
in general payments reported to CMS, 2019-2025
17 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $114 · 2022: $737 · 2023: $1,106 · 2024: $773 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,222.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $624.52 | 2022-2024 | Qelbree, Qelbree |
| Boston Scientific Corporation | $549.27 | 2022-2025 | General - Therapies, Watchman Access System, Emblem Mri S-Icd |
| Janssen Pharmaceuticals, INC | $329.95 | 2022-2025 | Spravato, Invega Sustenna |
| Otsuka America Pharmaceutical, INC. | $271.32 | 2021-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Alkermes, INC. | $256.72 | 2022-2024 | Lybalvi, Aristada, Vivitrol |
| Neurocrine Biosciences, INC. | $211.48 | 2022-2025 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $176.67 | 2022-2024 | Caplyta |
| Vanda Pharmaceuticals INC. | $161.32 | 2021-2022 | |
| Abbvie INC. | $107.84 | 2022-2025 | |
| Corium, LLC | $91.59 | 2023-2024 | Azstarys |
| Sunovion Pharmaceuticals INC. | $76.83 | 2021-2022 | |
| Lundbeck LLC | $73.59 | 2022-2023 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $52.80 | 2024 | Austedo Xr |
| E.R. Squibb & Sons, L.L.C. | $44.75 | 2025 | Cobenfy |
| Axsome Therapeutics, INC. | $15.29 | 2023 | Auvelity |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $15.18 | 2023 | Trintellix |
| Indivior INC. | $14.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.